Ucwaningo lwenziwa eRomania
- Ucwaningo lwenziwe i-MedLife Medical System, umholi wezokwelapha ezizimele e-Romania, futhi beluhloselwe ukuhlola izinga lokugoma elitholwe ngokwemvelo noma ngokulandela ukugoma e-Romania, ezingeni ledolobha.
- Ngokusho kodokotela be-MedLife, izinga lokugonywa kwemihlambi ezingeni lasemadolobheni lingaphezu kuka-60% wabantu, okusho ukuthi phakathi kwezakhamuzi eziyizigidi eziyisi-6 neziyi-7, kuphela emadolobheni amele u-54% wabantu baseRomania.
- Uma kubhekwa indawo yasemakhaya, isibalo salabo abathola lesi sifo noma abagonyiwe singafinyelela kubantu abayizigidi eziyi-10-12.
- Ngaphansi kwe-10% yalabo abathola lesi sifo kodwa abangagonywanga babonisa ama-titres amasosha omzimba aqeda amandla.[1]
- I-Romania ingaba yinkulisa ebaluleke kakhulu Europe kwezotshalomali nezokuvakasha. Lokhu, nokho, kubangelwa ukwanda okusheshayo kwamazinga okugoma.
Ibambe iqhaza ngentshiseko emisebenzini yocwaningo kusukela ekuqaleni kwalolu bhubhane, iMedLife Medical System, njengomholi wemboni eRomania, yenza ucwaningo olusha, ngokusebenzisa isigaba sayo socwaningo, ukuhlola izinga lokugoma okutholwe ngokwemvelo noma kulandela ukugonywa eRomania, edolobheni. izinga. Ucwaningo olunjalo lwenziwa kwisampula emele abantu abangama-943, izakhamizi emadolobheni anezici ezihlukile ngokwezinga lokugoma nezinga lokutheleleka: iBucharest, Cluj, Constanța, Timișoara - Zone 1, kanye neGiurgiu, Suceava kanye nePiatra Neamț - Zone 2, ngokulandelana. .
Ukuze kunqunywe i-antibody titre ngokumelene ne-COVID-19, ukuhlolwa kwe-RBD IgG (isiqephu samaprotheni) kuphrotheni ye-spike kwenziwa kusetshenziswa izinhlelo zokuhlaziya ze-Abbott, ezilinganise ngobuningi izinga lamasosha omzimba kanye nekhwalithi ye-nucleocapsid ye-SARS-CoV-2 (IgG) izivivinyo eziqinisekisa noma eziphika ubukhona bamasosha omzimba.
"Senza esidlangalaleni imiphumela yendlela entsha yocwaningo eyenziwe ngokuphelele ezinsizeni zethu futhi ngokukhethekile nodokotela nochwepheshe base-Romania. Idatha ibonisa ukuthi izinga lokugonywa komhlambi kuphela emadolobheni, eRomania, lingaphezu kuka-60%, okungukuthi ama-Romanian ayizigidi ezingu-6-7, okubonisa inqubekelaphambili enkulu yezinga lokugoma, njengoba ngoMeyi ngonyaka odlule thina, i-MedLife, imemezela, okokuqala ngqa, ukuthi ukungatheleleki kwabantu baseRomania ku-COVID-19 bekungaphansi kwama-2%. Ngaphezu kwalokho, uma sikhipha imininingwane futhi sicabangela indawo yasemakhaya, cishe sikhuluma ngabantu baseRomania abayizigidi eziyi-10-12 abathola lesi sifo noma bagonywa.. Nokho, lesi akusona isikhathi sokuphumula. Ucwaningo nge-Delta strain lubonisa ngaphandle kokungabaza ukuthi ukuzivikela kwemvelo, okutholakala ngemva kokuthola lesi sifo, akusebenzi ngokumelene nohlobo olusha lwe-Delta. I-Wave 4 iseduze kunalokho obekucatshangwa ekuqaleni, mhlawumbe ngenyanga eningizimu yaseRomania izogcina inezinkulungwane zamacala ngosuku ngenxa yalolu hlobo oluthelelanayo.
Kunesixazululo esisodwa kuphela: yokugoma. Ukube izinga eliphezulu lokugoma kwemvelo belihambisana nezinga eliphezulu ngokulinganayo lokugonywa okutholakala ngokugoma, iRomania cishe ngabe yenza kahle kakhulu ezingeni laseYurophu. Umkhankaso wokugoma ubonakale uhleleke kahle kakhulu ezweni lakithi, futhi unendawo enhle kakhulu kanye nokuba khona kwezimpahla zokugoma, kodwa ukwanda okukhulu kokuxhumana kuyadingeka ukuze kwaziwe abantu ngokubaluleka kwalesi simo kanye nokwenyusa amazinga okugoma njengoba ngokushesha ngangokunokwenzeka. Uma sibeka phambili ukugoma esikhathini esizayo, sinethuba lokuba yinkulisa ebaluleke kakhulu eYurophu ekutshalweni kwezimali nezokuvakasha”, kusho uMihai Marcu, uMongameli kanye ne-CEO ye-MedLife Group.
Abantu abaphindwe kathathu emadolobheni amakhulu aseRomania bangenwe yigciwane le-SARS-CoV-2 uma kuqhathaniswa nemibiko esemthethweni. Emadolobheni amancane, amanani akhuphuka ngokushaqisayo
Ucwaningo olwenziwe ngongoti be-MedLife lukhombisa ukuthi abantu abaphindwe kathathu emadolobheni amakhulu aseRomania bangenwe yigciwane le-SARS-CoV-2, uma kuqhathaniswa nemibiko esemthethweni ekhombisa kuphela isibalo sabantu abathole lesi sifo futhi bahlolelwa i-PCR. qinisekisa ukuxilongwa. Ngakho-ke, ngokusho kokuhlolwa kwe-serological okwenziwa ngesikhathi se-MedLife, ama-34% abantu abafundelwa emadolobheni amakhulu bake bangenwa ukutheleleka nge-COVID-19 selokhu kwaqala lolu bhubhane kuya phambili. Kulokhu, ngaphezu kwesigamu kwakungenzeka ukuthi ku-asymptomatic. Ngaphezu kwalokho, ucwaningo olufanayo lubonisa ukuthi u-50% wabantu basemadolobheni amancane bathola lesi sifo, kuze kube izikhathi eziyisishiyagalolunye ngaphezu kwezibalo ezibikwe ngokusemthethweni.
Kodwa-ke, isimo sisalokhu sikhathaza eRomania, njengoba abantu abathola lesi sifo futhi bengakagonywa banethuba elihle kakhulu lokuphinda batheleleke ngezinhlobo ezintsha ze-coronavirus manje ezisatshalaliswa. Futhi, ngokungafani namazwe aseNtshonalanga Yurophu, abantu abaneminyaka engaphezu kwengama-60, abachayeka kakhulu ezinhlotsheni ezinzima zesifo, okuhlanganisa ukulaliswa esibhedlela ngisho nokufa, bakhethe ukugonywa ngokwezinga elincane kakhulu.
Ngaphandle kwezinga lokugonywa komhlambi, iRomania isekude nokuphela kwalolu bhubhane
Yize imininingwane ngezinga lokugonywa komhlambi inethemba, ithimba labacwaningi be-MedLife lixwayisa ngokuthi igagasi lesine lalolu bhubhane alinakugwenywa nokuthi imiphumela yalo ohlelweni lwezempilo lwaseRomania kanye nomnotho izoba mibi kakhulu uma izinga lokugoma linganyuki ngokushesha inkathi elandelayo.
Lokhu kuchazwa yiqiniso lokuthi ngaphansi kuka-10% walabo abahlangane naleli gciwane, kodwa bengagonywanga, bane-antibody titre enciphisa amandla. Kodwa-ke, odokotela be-MedLife baveza ukuthi umphumela wokugoma kanye nomlando we-COVID-19 unamandla kakhulu, njengoba u-84% walabo abathola lesi sifo futhi bagonywa bene-antibody titre engasebenzi, okuhlanganisa nohlobo lweDelta.
"Izinga eliphezulu lokungavikeleki komhlambi emadolobheni lingasinika umbono wokuthi isimo siyalawuleka, kodwa, ngeshwa, kusekude nokuqeda lolu bhubhane. Sesiyazi kakade ukuthi esimweni seziguli ezingenazimpawu zesifo noma abantu abanezinhlobo ezithambile zesifo, inani lalabo okungenzeka ukuthi bangazange bakhiqize amasosha omzimba ngenxa yokuxhumana naleli gciwane, noma abakha i-antibody titre ephansi liphezulu uma liqhathaniswa ababenezinhlobo ezinzima zesifo. Ngakho-ke, kunokuhlukahluka kokusabela kokuzivikela komzimba ekuthelelekeni ngegciwane, ikakhulukazi uma kukhulunywa ngezinhlobo ezintsha, njengohlobo lweDelta, oludlondlobala kakhulu ezweni lakithi futhi okungenzeka lube namandla esikhathini esilandelayo. Ngakho-ke, kulo mzuzu, ukugoma ukuphela kwendlela yokuzivikela kuleli gciwane, futhi uma singakhulisi izinga lokugoma, cishe, ekwindla, izibhedlela zaseRomania zizoqala ukubhekana nemiphumela yalesi sigameko sesine. yobhubhane“, kusho uDumitru Jardan, isazi sezinto eziphilayo ophikweni locwaningo lwe-MedLife Group.
Ubufakazi beqiniso lokuthi imisebenzi yokugoma ihlinzekwa yiyo kanye inhloko-dolobha yaseRomania, iBucharest, ebonakala inenani eliphakeme kakhulu lokugoma ezweni. Imininingwane ehlaziywe ikhombisa ukuthi cishe ama-70% azo zonke izakhamizi zaseBucharest athola ukungavikeleki ku-COVID-19 ngokwemvelo noma ngokugonywa, futhi lokhu kuhlotshaniswa nezinga eliphezulu lokugoma eliqoshwe eBucharest.
IMedLife, okuwukuphela kwenkampani ezimele yezokwelapha eRomania etshale izimali ezinkulu ocwaningweni futhi yakwazi ukuqapha lo bhubhane ngeqhaza elikhulu emphakathini.
Njengenkampani enkulu kunazo zonke ezimele yezokwelapha e-Romania futhi okuwukuphela kwayo etholakala ezweni lonke, i-MedLife ibikhathazeke ngezempilo yomphakathi futhi ibambe iqhaza elikhulu ekuqapheni ubhubhane, yenza izifundo ezibanzi nodokotela baseRomania, izazi zebhayoloji nabacwaningi. Kusukela ezinyangeni zokuqala zalolu bhubhane, inkampani yagxila emizamweni nezinsizakusebenza zayo ukuqapha inqubekelaphambili yezifo eziwubhubhane ezweni, futhi ibe neqhaza elikhulu ekwaziseni abantu neziphathimandla zaseRomania.
Eqinisweni, inkampani kumanje isebenza ocwaningweni lokuqala esifundeni oluhlola ukuphendula kwamasosha omzimba ngokumelene ne-COVID-19, futhi maduze izobuya nolwazi olubalulekile lokuqhubeka kwalolu bhubhane maqondana nokumelana kwalabo abanalesi sifo. ukutheleleka okusha.
***
I-MedLife Medical System ukuphela kwe-opharetha e-Romania ekhathazeke ngempela ngezempilo yomphakathi kusukela ekuqaleni kwalolu bhubhane, eyenze izifundo ezingekho ngaphansi kweziyi-9 kuphela ngezimali nezinsiza zayo, ezibandakanya odokotela nabacwaningi baseRomania. Ngakho-ke, inkampani inikeze iziphathimandla imininingwane ebalulekile mayelana nokugonywa kwemvelo kwabantu, ezingeni likazwelonke kanye nokuqubuka okuthile, ukuvela okunamandla kwamasosha omzimba ku-COVID-19, umsuka wegciwane le-SARS-CoV-2 elizungeza eRomania, kanye indlela yokudlulisela noma ukuba khona kwezinye izinhlobo.
Ukutshalwa kwezimali kwe-MedLife ezenzweni zocwaningo kufinyelela kuma-euro angaphezu kwezigidi ezimbili kusukela kwaqala lolu bhubhane. Uhlelo locwaningo lwenziwa kuphela ezikhwameni zenkampani uqobo.
Le nkampani iyaqhubeka nokutshala imali ocwaningweni, futhi njengamanje yenza ucwaningo lokuqala esifundeni mayelana nokusabela kokuzivikela komzimba kumaselula ngokumelene ne-COVID-19, imiphumela yayo ezobaluleka ekuqubukeni kwalolu bhubhane.
[1] Amanani >= 3950 AU/ml aye alinganiswa namathuba angu-95% anama-neutralization titres >= 1:250 (PRNT ID50). Imiphumela etholwe kwezinye izinkundla zokuhlaziya ayinakuqhathaniswa.
